Cargando…
Biowaiver Monographs for Immediate Release Solid Oral Dosage Forms: Ribavirin
Literature data relevant to the decision to allow a waiver of in vivo bioequivalence (BE) testing for the approval of immediate release solid oral dosage forms containing ribavirin are reviewed. Ribavirin is highly soluble, but its permeability characteristics are not well defined. Therefore accordi...
Autores principales: | Goodarzi, Navid, Barazesh Morgani, Ahmadreza, Abrahamsson, Bertil, Cristofoletti, Rodrigo, Groot, D.W., Langguth, Peter, Mehta, Mehul U., Polli, James E., Shah, Vinod P., Dressman, Jennifer B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Pharmacists Association®. Published by Elsevier Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7126353/ https://www.ncbi.nlm.nih.gov/pubmed/26952879 http://dx.doi.org/10.1016/j.xphs.2016.01.017 |
Ejemplares similares
-
Evaluation of Excipient Risk in BCS Class I and III Biowaivers
por: Metry, Melissa, et al.
Publicado: (2022) -
Overview of the European Medicines Agency's Experience With Biowaivers in Centralized Applications
por: Lenić, Ines, et al.
Publicado: (2019) -
Automatic identification and normalization of dosage forms in drug monographs
por: Li, Jiao, et al.
Publicado: (2012) -
Interchangeability Evaluation of Multisource Ibuprofen Drug Products Using Biowaiver Procedure
por: Shohin, I. E., et al.
Publicado: (2011) -
The Effect of Excipients on the Permeability of BCS Class III Compounds and Implications for Biowaivers
por: Parr, Alan, et al.
Publicado: (2015)